File Download
 
 
Supplementary

Conference Paper: Prostaglandin E2-EP4 signaling reduces inflammation in mouse adipose tissue
  • Basic View
  • Metadata View
  • XML View
TitleProstaglandin E2-EP4 signaling reduces inflammation in mouse adipose tissue
 
AuthorsTang, EHC
Wong, CK
Xu, A
Vanhoutte, PM
 
KeywordsMedical sciences
Cardiovascular diseases
 
Issue Date2012
 
PublisherS Karger AG. The Journal's web site is located at http://www.karger.com/JVR
 
CitationEDHF 2012 - 10th Anniversary Meeting, Vaux-de-Cernay, France, 27-30 June 2012. In Journal of Vascular Research, 2012, v. 49 suppl. 2, abstract no. 46 [How to Cite?]
 
AbstractInflammation of adipose tissue plays a causative role in inducing metabolic syndrome associated with obesity. Thus examining ways to control or inhibit adipose tissue inflammation is of clinical interest. In the present study, we were interested to see if endogenous prostaglandin E2 (PGE2) modulates inflammation via activation of EP4 receptors in mouse adipose tissue. PGE2 (5-500nM) attenuated lipopolysaccharide (LPS)-induced mRNA and protein expression of chemokines in mouse adipose tissue, including interferon-γ-inducible protein 10 (IP10) and macrophage-inflammatory protein (MIP)-1α. Such response was reversed with L161,982 (100nM, a selective EP4 antagonist), mimicked with two structurally different selective EP4 agonists [CAY10580 (10μM) and CAY10598 (10μM)], and was absence in adipose tissue derived from EP4-deficient mice. These findings consolidated the requirement of EP4 in the response. PGE2 significantly reduced LPS-induced chemokines in mature adipocytes, rather than in stromal vascular cells. Antiinflammatory effect of PGE2 in adipose tissue was mimicked with 8-bromo-cyclic adenosine monophosphoate (cAMP) but was insensitive to H98 (a protein kinase A inhibitor). The use of adipose tissue from high-fat fed mice confirmed that EP4-dependent anti-inflammatory response is sustained during diet-induced obesity. Furthermore, adipose tissue and systemic inflammation is enhanced in high-fat fed EP4 deficient mice as compared to wild-type littermates, providing in vivo evidences that PGE2-EP4 signaling modulates inflammation. Our work illustrated that PGE2 via activation of EP4 is a potential endogenous anti-inflammatory mediator in mouse adipose tissue and targeting EP4 could be a strategy to mitigate adipose tissue inflammation.
 
DescriptionThis journal suppl. contain abstracts of EDHF 2012 - 10th Anniversary Meeting
 
ISSN1018-1172
2013 Impact Factor: 2.443
 
DC FieldValue
dc.contributor.authorTang, EHC
 
dc.contributor.authorWong, CK
 
dc.contributor.authorXu, A
 
dc.contributor.authorVanhoutte, PM
 
dc.date.accessioned2012-09-20T08:18:22Z
 
dc.date.available2012-09-20T08:18:22Z
 
dc.date.issued2012
 
dc.description.abstractInflammation of adipose tissue plays a causative role in inducing metabolic syndrome associated with obesity. Thus examining ways to control or inhibit adipose tissue inflammation is of clinical interest. In the present study, we were interested to see if endogenous prostaglandin E2 (PGE2) modulates inflammation via activation of EP4 receptors in mouse adipose tissue. PGE2 (5-500nM) attenuated lipopolysaccharide (LPS)-induced mRNA and protein expression of chemokines in mouse adipose tissue, including interferon-γ-inducible protein 10 (IP10) and macrophage-inflammatory protein (MIP)-1α. Such response was reversed with L161,982 (100nM, a selective EP4 antagonist), mimicked with two structurally different selective EP4 agonists [CAY10580 (10μM) and CAY10598 (10μM)], and was absence in adipose tissue derived from EP4-deficient mice. These findings consolidated the requirement of EP4 in the response. PGE2 significantly reduced LPS-induced chemokines in mature adipocytes, rather than in stromal vascular cells. Antiinflammatory effect of PGE2 in adipose tissue was mimicked with 8-bromo-cyclic adenosine monophosphoate (cAMP) but was insensitive to H98 (a protein kinase A inhibitor). The use of adipose tissue from high-fat fed mice confirmed that EP4-dependent anti-inflammatory response is sustained during diet-induced obesity. Furthermore, adipose tissue and systemic inflammation is enhanced in high-fat fed EP4 deficient mice as compared to wild-type littermates, providing in vivo evidences that PGE2-EP4 signaling modulates inflammation. Our work illustrated that PGE2 via activation of EP4 is a potential endogenous anti-inflammatory mediator in mouse adipose tissue and targeting EP4 could be a strategy to mitigate adipose tissue inflammation.
 
dc.descriptionThis journal suppl. contain abstracts of EDHF 2012 - 10th Anniversary Meeting
 
dc.identifier.citationEDHF 2012 - 10th Anniversary Meeting, Vaux-de-Cernay, France, 27-30 June 2012. In Journal of Vascular Research, 2012, v. 49 suppl. 2, abstract no. 46 [How to Cite?]
 
dc.identifier.hkuros211041
 
dc.identifier.hkuros201393
 
dc.identifier.issn1018-1172
2013 Impact Factor: 2.443
 
dc.identifier.issuesuppl. 2
 
dc.identifier.urihttp://hdl.handle.net/10722/165459
 
dc.identifier.volume49
 
dc.languageeng
 
dc.publisherS Karger AG. The Journal's web site is located at http://www.karger.com/JVR
 
dc.publisher.placeSwitzerland
 
dc.relation.ispartofJournal of Vascular Research
 
dc.rightsJournal of Vascular Research. Copyright © S Karger AG.
 
dc.subjectMedical sciences
 
dc.subjectCardiovascular diseases
 
dc.titleProstaglandin E2-EP4 signaling reduces inflammation in mouse adipose tissue
 
dc.typeConference_Paper
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Tang, EHC</contributor.author>
<contributor.author>Wong, CK</contributor.author>
<contributor.author>Xu, A</contributor.author>
<contributor.author>Vanhoutte, PM</contributor.author>
<date.accessioned>2012-09-20T08:18:22Z</date.accessioned>
<date.available>2012-09-20T08:18:22Z</date.available>
<date.issued>2012</date.issued>
<identifier.citation>EDHF 2012 - 10th Anniversary Meeting, Vaux-de-Cernay, France, 27-30 June 2012. In Journal of Vascular Research, 2012, v. 49 suppl. 2, abstract no. 46</identifier.citation>
<identifier.issn>1018-1172</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/165459</identifier.uri>
<description>This journal suppl. contain abstracts of EDHF 2012 - 10th Anniversary Meeting</description>
<description.abstract>Inflammation of adipose tissue plays a causative role in inducing metabolic syndrome associated with obesity. Thus examining ways to control or inhibit adipose tissue inflammation is of clinical interest. In the present study, we were interested to see if endogenous prostaglandin E2 (PGE2) modulates inflammation via activation of EP4 receptors in mouse adipose tissue. PGE2 (5-500nM) attenuated lipopolysaccharide (LPS)-induced mRNA and protein expression of chemokines in mouse adipose tissue, including interferon-&#947;-inducible protein 10 (IP10) and macrophage-inflammatory protein (MIP)-1&#945;. Such response was reversed with L161,982 (100nM, a selective EP4 antagonist), mimicked with two structurally different selective EP4 agonists [CAY10580 (10&#956;M) and CAY10598 (10&#956;M)], and was absence in adipose tissue derived from EP4-deficient mice. These findings consolidated the requirement of EP4 in the response. PGE2 significantly reduced LPS-induced chemokines in mature adipocytes, rather than in stromal vascular cells. Antiinflammatory effect of PGE2 in adipose tissue was mimicked with 8-bromo-cyclic adenosine monophosphoate (cAMP) but was insensitive to H98 (a protein kinase A inhibitor). The use of adipose tissue from high-fat fed mice confirmed that EP4-dependent anti-inflammatory response is sustained during diet-induced obesity. Furthermore, adipose tissue and systemic inflammation is enhanced in high-fat fed EP4 deficient mice as compared to wild-type littermates, providing in vivo evidences that PGE2-EP4 signaling modulates inflammation. Our work illustrated that PGE2 via activation of EP4 is a potential endogenous anti-inflammatory mediator in mouse adipose tissue and targeting EP4 could be a strategy to mitigate adipose tissue inflammation.</description.abstract>
<language>eng</language>
<publisher>S Karger AG. The Journal&apos;s web site is located at http://www.karger.com/JVR</publisher>
<relation.ispartof>Journal of Vascular Research</relation.ispartof>
<rights>Journal of Vascular Research. Copyright &#169; S Karger AG.</rights>
<subject>Medical sciences</subject>
<subject>Cardiovascular diseases</subject>
<title>Prostaglandin E2-EP4 signaling reduces inflammation in mouse adipose tissue</title>
<type>Conference_Paper</type>
<identifier.hkuros>211041</identifier.hkuros>
<identifier.hkuros>201393</identifier.hkuros>
<identifier.volume>49</identifier.volume>
<identifier.issue>suppl. 2</identifier.issue>
<publisher.place>Switzerland</publisher.place>
</item>